A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines
Status
Status :
Completed
Type of study
Phase II
Min. Age
60
Years old
Max. Age
-
Gender
All
Therapeutic area :
Oncology
Disease :
Metastatic breast cancer
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Start Date :
30 September 2004
End date :
01 June 2007
Study ID :
PM0259 CA 221 B0
EudraCT/CTIS number :
2004-000963-81
Send by email